DNA-thioguanine nucleotide as a treatment marker in acute lymphoblastic leukemia patients with NUDT15 variant genotypes

BACKGROUND: Large inter-individual variations in drug metabolism pose a challenge in determining 6-mercaptopurine (6MP) doses. As the last product of 6MP metabolism, DNA-thioguanine nucleotide (DNA-TGN) could reflect the efficacy of 6MP, especially in patients harboring variants in the 6MP metabolis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Hee Young, Lee, Ji Won, Cho, Hee Won, Hyun, Ju Kyung, Ma, Youngeun, Yi, Eun Sang, Yoo, Keon Hee, Sung, Ki Woong, Choi, Rihwa, Koo, Hong Hoe, Lee, Soo-Youn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822258/
https://www.ncbi.nlm.nih.gov/pubmed/33481917
http://dx.doi.org/10.1371/journal.pone.0245667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822258/
https://www.ncbi.nlm.nih.gov/pubmed/33481917
http://dx.doi.org/10.1371/journal.pone.0245667

Ejemplares similares